Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Sotera Health Company

Berenberg Bank analyst maintained a Hold rating on Shaftesbury Capital yesterday and set a price target of p151.00. The company’s shares closed yes...

Shaftesbury Capital (SHC) Receives a Hold from Berenberg Bank

Shaftesbury Capital ( ($GB:SHC) ) has issued an announcement. Shaftesbury Capital has confirmed the exchange rate and tax treatment for its propose...

Shaftesbury Capital Sets Exchange Rate and Tax Terms for 2025 Final Dividend

An announcement from Shaftesbury Capital ( ($GB:SHC) ) is now available. Shaftesbury Capital PLC has applied for the admission of 7,000,000 new ord...

Shaftesbury Capital Seeks Admission of 7 Million New Shares for Performance Plan

Shaftesbury Capital ( ($GB:SHC) ) has provided an announcement. Shaftesbury Capital PLC has published its Annual Report for the year ended 31 Decem...

Market Cap	$4.55B	P/E Ratio	17.36
52W High	$19.85	52W Low	$9.53
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	-26.9%	52W Position	55.7%
Overall Score	50	Value Score	40
Quality Score	47	Technical Score	63

EPS Current Est	$0.88	EPS Next Est	$0.98
EPS Growth Est	+11.4%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SHC	$15.28	0.00%	1.86M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	SHC	$15.28	0%	1.86M
3
4
5
6

SHC

SHC

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Sotera Health Company Data in Excel

Get Sotera Health Company Data in Excel